DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
PHENTERMINE HYDROCHLORIDE; TOPIRAMATE
4
Combination
Approved
DIABETES DRUGS & ENDOCRINOLOGY; OTHER
ORAL
Unknown
Unknown
PHENTERMINE HYDROCHLORIDE; TOPIRAMATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TRICHLOROETHANE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
TRICHLOROETHANE
×
Maximum Phase:
4
First Approval:
None
UNII:
113C650IR1
Molecule Type:
Small molecule
Molecular Formula:
C2H3Cl3
Molecular Weight:
133.41
AlogP:
2.38
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
0.0
Source:
HYDROCORTISONE; NEOMYCIN SULFATE
4
Combination
Approved
OTHER
TOPICAL
Unknown
Unknown
HYDROCORTISONE; NEOMYCIN SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MENADIOL DIPHOSPHORIC ACID
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
MENADIOL DIPHOSPHORIC ACID
×
Maximum Phase:
4
First Approval:
None
UNII:
GRL65FEU3T
Molecule Type:
Small molecule
Molecular Formula:
C11H12O8P2
Molecular Weight:
334.16
AlogP:
2.09
PSA:
133.52
HBD:
4.0
HBA:
#RotB:
4.0
Source:
CALCIUM CARBONATE; RISEDRONATE SODIUM
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
CALCIUM CARBONATE; RISEDRONATE SODIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMLODIPINE BESYLATE; CELECOXIB
4
Combination
Approved
Unknown
ORAL
Unknown
Unknown
AMLODIPINE BESYLATE; CELECOXIB
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SOY ISOFLAVONES
4
Unknown
Approved
Unknown
Unknown
Alzheimer Disease; Depressive Disorder
Unknown
SOY ISOFLAVONES
×
Maximum Phase:
4
First Approval:
None
UNII:
71B37NR06D
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PHENOBARBITAL
4
Small molecule
Unknown
Unknown
Unknown
Lymphoma; Neutropenia; Anxiety; Dementia; Depressive Disorder; Neonatal Abstinence Syndrome; Schizophrenia; Seizures; Status Epilepticus; Epilepsy
Unknown
PHENOBARBITAL
×
Maximum Phase:
4
First Approval:
None
UNII:
YQE403BP4D
Molecule Type:
Small molecule
Molecular Formula:
C12H12N2O3
Molecular Weight:
232.24
AlogP:
0.7
PSA:
75.27
HBD:
2.0
HBA:
#RotB:
2.0
Source:
KALLIDINOGENASE
4
Enzyme
Approved
Unknown
Unknown
Cerebral Infarction
Unknown
KALLIDINOGENASE
×
Maximum Phase:
4
First Approval:
None
UNII:
OT9M1PSK9N
Molecule Type:
Enzyme
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FOLLITROPIN ALFA/BETA
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
FOLLITROPIN ALFA/BETA
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PROMETHAZINE HYDROCHLORIDE; CODEINE PHOSPHATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
PROMETHAZINE HYDROCHLORIDE; CODEINE PHOSPHATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BENZOYL PEROXIDE; ERYTHROMYCIN
4
Combination
Approved
DERMATOLOGY; OTHER
TOPICAL
Unknown
Unknown
BENZOYL PEROXIDE; ERYTHROMYCIN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MEPHENESIN
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
MEPHENESIN
×
Maximum Phase:
4
First Approval:
None
UNII:
7B8PIR2954
Molecule Type:
Small molecule
Molecular Formula:
C10H14O3
Molecular Weight:
182.22
AlogP:
0.73
PSA:
49.69
HBD:
2.0
HBA:
#RotB:
4.0
Source:
IOTHALAMATE SODIUM I-125
4
Small molecule
Approved
OTHER
INJECTION
Unknown
Unknown
IOTHALAMATE SODIUM I-125
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM CITRATE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM CITRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMPHETAMINE ADIPATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE ADIPATE; DEXTROAMPHETAMINE SULFATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
AMPHETAMINE ADIPATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE ADIPATE; DEXTROAMPHETAMINE SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CANTHARIDIN
4
Small molecule
Approved
Unknown
Unknown
Arthritis, Rheumatoid; Inflammation; Molluscum Contagiosum
Unknown
CANTHARIDIN
×
Maximum Phase:
4
First Approval:
None
UNII:
IGL471WQ8P
Molecule Type:
Small molecule
Molecular Formula:
C10H12O4
Molecular Weight:
196.2
AlogP:
0.64
PSA:
52.6
HBD:
0.0
HBA:
#RotB:
0.0
Source:
DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PCC
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
PCC
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SACITUZUMAB GOVITECAN-HZIY
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
SACITUZUMAB GOVITECAN-HZIY
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CLAMOXYL
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
CLAMOXYL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BUNAZOSIN
4
Small molecule
Approved
Unknown
Unknown
Unknown
Adrenergic receptor alpha-1 antagonist
BUNAZOSIN
×
Maximum Phase:
4
First Approval:
None
UNII:
9UUW4V7G2H
Molecule Type:
Small molecule
Molecular Formula:
C19H27N5O3
Molecular Weight:
373.46
AlogP:
2.07
PSA:
93.81
HBD:
1.0
HBA:
#RotB:
5.0
Source:
BUTAMBEN PICRATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Transient receptor potential cation channel subfamily A member 1 inhibitor
BUTAMBEN PICRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
D4ZFB7ZH5Y
Molecule Type:
Small molecule
Molecular Formula:
C28H33N5O11
Molecular Weight:
615.6
AlogP:
2.23
PSA:
52.32
HBD:
1.0
HBA:
#RotB:
4.0
Source:
CHLOROFORM
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
CHLOROFORM
×
Maximum Phase:
4
First Approval:
None
UNII:
7V31YC746X
Molecule Type:
Small molecule
Molecular Formula:
CHCl3
Molecular Weight:
119.38
AlogP:
1.99
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
0.0
Source:
FONAZINE
4
Small molecule
Approved
Unknown
Unknown
Migraine Disorders
Unknown
FONAZINE
×
Maximum Phase:
4
First Approval:
None
UNII:
1FTA475ZDB
Molecule Type:
Small molecule
Molecular Formula:
C19H25N3O2S2
Molecular Weight:
391.56
AlogP:
3.49
PSA:
43.86
HBD:
0.0
HBA:
#RotB:
5.0
Source:
TECHNETIUM TC-99M DEPREOTIDE
4
Protein
Approved
OTHER
INJECTION
Unknown
Unknown
TECHNETIUM TC-99M DEPREOTIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HYDROCHLOROTHIAZIDE; METOPROLOL SUCCINATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
HYDROCHLOROTHIAZIDE; METOPROLOL SUCCINATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TYPHOID VI POLYSACCHARIDE VACCINE
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
TYPHOID VI POLYSACCHARIDE VACCINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SULESOMAB TC
4
Antibody
Approved
Unknown
Unknown
Unknown
Unknown
SULESOMAB TC
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HEXYLRESORCINOL
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
HEXYLRESORCINOL
×
Maximum Phase:
4
First Approval:
None
UNII:
R9QTB5E82N
Molecule Type:
Small molecule
Molecular Formula:
C12H18O2
Molecular Weight:
194.27
AlogP:
3.22
PSA:
40.46
HBD:
2.0
HBA:
#RotB:
5.0
Source:
ALLYLESTRENOL
4
Small molecule
Approved
Unknown
Unknown
Unknown
Estrogen receptor agonist
ALLYLESTRENOL
×
Maximum Phase:
4
First Approval:
None
UNII:
I47VB5DZ8O
Molecule Type:
Small molecule
Molecular Formula:
C21H32O
Molecular Weight:
300.49
AlogP:
5.26
PSA:
20.23
HBD:
1.0
HBA:
#RotB:
2.0
Source:
TECHNETIUM TC 99M PENTETATE
4
Small molecule
Approved
Unknown
Unknown
Brain Neoplasms
Diagnostic agent
TECHNETIUM TC 99M PENTETATE
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C14H18N3NaO10Tc
Molecular Weight:
510.21
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
NEFOPAM HYDROCHLORIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
NEFOPAM HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
685J48E13W
Molecule Type:
Small molecule
Molecular Formula:
C17H20ClNO
Molecular Weight:
289.81
AlogP:
3.24
PSA:
12.47
HBD:
0.0
HBA:
#RotB:
1.0
Source:
RESERPINE; TRICHLORMETHIAZIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
RESERPINE; TRICHLORMETHIAZIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHLORAMPHENICOL; HYDROCORTISONE ACETATE; POLYMYXIN B SULFATE
4
Combination
Approved
OTHER
OPHTHALMIC
Unknown
Unknown
CHLORAMPHENICOL; HYDROCORTISONE ACETATE; POLYMYXIN B SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
283
284
285
286
287
288
289
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA